Compare Antimicrobial to Conventional Suture in Patients Receiving Primary Total Knee Replacement
NCT ID: NCT02533492
Last Updated: 2015-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
102 participants
INTERVENTIONAL
2011-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symmetric on Total Knee Arthroplasty (TKA)
NCT03305887
Comparison of Surgical Site Infection After Skin Closure by Prolene or Staples in Bilateral Knee Arthroplasty Patients
NCT04492852
IO vs IV Vancomycin in Tourniquetless TKA
NCT05705843
IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA
NCT07283068
Intrawound Administration of Vancomycin in TKA
NCT05338021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Compare the results of Antimicrobial with Conventional suture materials in patients receiving primary total knee replacement: a prospective double-blinded randomized controlled trial
Objectives:
Primary Objective: To investigate whether the surgical site infection rate after total knee replacement will be different with two different suture materials.
Secondary Objective: To investigate the surrogating markers for inflammatory response and functional outcomes with two different suture materials.
Rationale:
The reported rate of deep infection following contemporary total knee replacement has been about two percent. The prevalence of prolonged wound drainage of soft tissue complications is between 17 to 50% of patients in whom 1.3% of them eventually developed culture-proved prosthetic infection. Total knee infections typically require complete removal of the prosthesis and prolonged antibiotic treatment. Re-infection rate following revision surgery for infected total knee cases is also significantly higher than those without infection complications. Total knee infections are devastating and associated with prolonged hospital stays, increased co-morbidity, and utilization of medical resources. Measures to reduce the infection rate extensively implemented clinically. However the use of antibacterial suture materials to reduce the wound complications has not yet been investigated before. Clinical trials including this issue only had been discussed in animal studies for minimal series. The effectiveness of the new material should be checked.
This study is designed to investigate the wound conditions and deep infection incidence following total knee replacement performed using either antimicrobial or conventional sutures. A prospective, double-blinded, randomized controlled trial with 102 patients evenly distributed into two groups is proposed. Each group has 51 patients scheduled for unilateral total knee replacement. Randomization is by envelope-drawing to minimize confounding risk factors. One hundred and two sets of suture materials (51 sets of Vicryl Plus and 51 sets of Vicryl) will be separately put into sealed envelopes. The envelopes are randomly assigned with consecutive numbers from 1 to 102. The envelopes are randomly given to the patients for wound closure. Finally, one group of patients will receive antibacterial sutures (VICRYL Plus, Ethicon, Johnson and Johnson, Taipei, Taiwan) following total knee replacement for the wound closure and the other group of patients will receive conventional sutures (VICRYL, Ethicon, Johnson and Johnson, Taipei, Taiwan) following total knee replacement for the wound closure. Group sample sizes of 51 and 51 achieve 81% power to detect a difference of -4% between the null hypothesis that both group means are 9.0 and the alternative hypothesis that the mean is 13.0 with estimated group standard deviations of 6.0 and 8.0 and with a significance level (alpha) of 0.05 using a two-sided two-sample t-test. The primary outcome measure is the incidence of prosthetic infection within three months of surgery. The secondary outcome measures include hospital stay, duration of antibiotics use, pain scale (VAS), wound conditions (wound drainage, extent of erythema, local heat, temperature), and serum parameters during hospitalization and within three months after operation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vicryl
Vicryl suture for wound closure after total knee replacement
vicryl
wound closure with vicryl suture
vicryl plus
Vicryl plus suture for wound closure after total knee replacement
Vicryl plus
wound closure with vicryl plus suture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vicryl
wound closure with vicryl suture
Vicryl plus
wound closure with vicryl plus suture
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any age
* Varus/valgus deformity knee
Exclusion Criteria
* Systemic diseases with coagulopathy
* Immune compromise(ESRD, liver cirrhosis)
* PAOD or DVT history
* Pre-OP INR \>1.5
* ASA score \>3
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson
INDUSTRY
Mel Shiuann-Sheng Lee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mel Shiuann-Sheng Lee
Chang Gung Memorial Hospital, Dept Orthopedic Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung Memorial Hospital
Kweishan, Taoyuan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008 Aug;2(2):111-7. doi: 10.3171/PED/2008/2/8/111.
Lin SJ, Chang FC, Huang TW, Peng KT, Shih HN, Lee MS. Temporal Change of Interleukin-6, C-Reactive Protein, and Skin Temperature after Total Knee Arthroplasty Using Triclosan-Coated Sutures. Biomed Res Int. 2018 Jan 15;2018:9136208. doi: 10.1155/2018/9136208. eCollection 2018.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
98-2933a3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.